Skip to content

Clinical trials

Terminated Observational Myeloproliferative Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Phase: Observational Status: Terminated Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20071
20083
20092
20101
20161

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vanderbilt-Ingram Cancer Center3
Centre Hospitalier Universitaire de Nice1
City of Hope Medical Center1
Columbia University1
OHSU Knight Cancer Institute1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1
Stanford University1
University of Utah1
Vanderbilt University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders11
Blast Crisis8
Burkitt Lymphoma8
Congenital Abnormalities8
Hodgkin Disease8
Leukemia, Lymphocytic, Chronic, B-Cell8
Leukemia, Myeloid, Accelerated Phase8
Leukemia, Myeloid, Acute8
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative8
Leukemia, Myeloid, Chronic-Phase8

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.